Thymosin beta-4 enhanced diabetic stem cell migration and blood vessel formation in vitro and increased capillary density after heart attack in diabetic rats, but did not improve overall heart pumping function.
More vessels, same functionTβ4-treated cells increased capillary density but did not improve heart ejection fraction in diabetic rats
What the researchers found
Tβ4 at 10 ng/mL improved diabetic EPC migration, tubule formation, and angiogenic factor secretion in vitro, and increased capillary density in vivo, but only non-Tβ4-treated EPCs significantly improved left ventricular ejection fraction.
Why it matters
Heart disease is the leading killer of diabetic patients, and their stem cells are impaired. Finding ways to restore diabetic stem cell function could improve outcomes after heart attacks in this vulnerable population.
The numbers in context
10 ng/mL Tb4; MRI at 2, 4, 12 weeks; increased capillary density and c-Kit+ cells; no EF improvement
How the study worked
In vitro: Tβ4 treatment of diabetic EPCs measuring migration, tube formation, and growth factor secretion. In vivo: intramyocardial injection of Tβ4-treated vs untreated diabetic EPCs in obese diabetic rats after induced heart attack, measuring capillary density, progenitor cell recruitment, and cardiac function.
Who was studied
Obese diabetic rats with induced myocardial infarction
What this study cannot tell us
Small animal model with unspecified group sizes. The paradox of improved vessel formation but not heart function is unexplained. Single Tβ4 dose tested. Short follow-up period likely.
How to read the evidence
Preliminary — small animal study with mixed results. The disconnect between vessel formation and cardiac function requires further investigation.
When this study was published
Published in 2020; thymosin beta-4 cardiac research continues with focus on optimizing dosing and delivery strategies.
The bigger picture
This study highlights the complexity of stem cell therapy in diabetes — improving individual cell behaviors (migration, vessel formation) does not automatically translate to improved organ-level function, suggesting additional factors affect cardiac recovery.
Questions still open
- Why did Tβ4-treated EPCs increase vessel density but fail to improve ejection fraction?
- Would different Tβ4 doses or timing produce better cardiac function outcomes?
- Could combining Tβ4 with other cardiac repair peptides like BPC-157 improve results?
Common questions
What is thymosin beta-4 and why test it on heart attack?
Why might more blood vessels not help heart function?
Read the original research
Transplantation of Endothelial Progenitor Cells in Obese Diabetic Rats Following Myocardial Infarction: Role of Thymosin Beta-4.
Cells, 9(4)
Citation
Poh, Kian Keong; Lee, Poay Sian Sabrina; Djohan, Andie Hartanto; Galupo, Mary Joyce; Songco, Geronica Gorospe; Yeo, Tiong Cheng; Tan, Huay Cheem; Richards, Arthur Mark; Ye, Lei. (2020). Transplantation of Endothelial Progenitor Cells in Obese Diabetic Rats Following Myocardial Infarction: Role of Thymosin Beta-4.. Cells, 9(4). https://doi.org/10.3390/cells9040949